Jed N Lampe

8PUBLICATIONS
29CO-AUTHORS
Biocatalysis and enzyme technologyPredictive and prognostic markersToxicology (incl. clinical toxicology)ChemotherapyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 30, 2026
New Mechanistic Evidence for Perfluorodecanoic Acid (PFDA) Teratogenicity via CYP26A1-Mediated Retinoic Acid Metabolism and Signaling.

Michaela Hvizdak, Sylvie E Kandel, Jed N Lampe

|May 03, 2024
Comparison of the CYP3A Selective Inhibitors CYP3cide, Clobetasol, and Azamulin for Their Potential to Distinguish CYP3A7 Activity in the Presence of CYP3A4/5.

Hannah M Work, Sylvie E Kandel, Jed N Lampe

|Jan 24, 2024
HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation.

Hannah M Work, John C Hackett, Jed N Lampe

|Sep 28, 2023
Consideration of Nevirapine Analogs To Reduce Metabolically Linked Hepatotoxicity: A Cautionary Tale of the Deuteration Approach.

Sylvie E Kandel, Emily G Gracey, Jed N Lampe

|Jun 02, 2023
Transcriptomics, metabolomics, and in-silico drug predictions for liver damage in young and aged burn victims.

Beata Malachowska, Weng-Lang Yang, Andrea Qualman

Pageof 2